US2012148590A1PendingUtilityA1
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
Est. expiryOct 12, 2019(expired)· nominal 20-yr term from priority
Inventors:Christophe Bonny
A61K 38/00C07K 14/4743C07K 2319/00C07K 2319/10
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides cell-permeable peptides that bind to JNK protein and inhibit JNK-mediated effects in JNK-expressing cells.
Claims
exact text as granted — not AI-modified1 .- 37 . (canceled)
38 . A D-enantiomeric peptide comprising the amino acid sequence of SEQ ID NO: 8, wherein said peptide facilitates transport across a biological membrane.
39 . A transport protein comprising a D-enantiomeric peptide, said D-enantiomeric peptide consisting of the amino acid sequence of SEQ ID NO: 8.
40 . A polypeptide comprising the peptide of claim 38 and a protein covalently bound to said peptide.
41 . A transport protein consisting of a D-enantiomeric peptide, said D-enantiomeric peptide consisting of the amino acid sequence of SEQ ID NO: 8.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.